Invitation to attend the extraordinary shareholders meeting of the Company to be held on July 9, 2026
REGULATED INFORMATIONJune 19, 2026, 10:30pm CET / 4:30pm ET NYXOAH SA(Euronext Brussels/Nasdaq:…
Information on the total number of voting rights and shares
REGULATED INFORMATION Information on the total number of voting rights and shares…
Invitation to attend the annual and the extraordinary shareholders meetings of the Company to be held on June 10, 2026
REGULATED INFORMATIONMay 8, 2026, 10:05pm CET / 4:05pm ET NYXOAH SA(Euronext Brussels/Nasdaq:…
Publication relating to transparency notification
REGULATED INFORMATION Publication relating to transparency notification Mont-Saint-Guibert (Belgium), March 13, 2026,…
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services…
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
INSIDE INFORMATIONREGULATED INFORMATION Correction and ReplacementNyxoah Secures Financing Commitments of up to…
Publication relating to transparency notifications
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 3, 2025,…
Nyxoah Announces Preliminary Results for the Second Quarter of 2025
Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Mont-Saint-Guibert, Belgium…
